Exosomes as key mediators in immune and cancer cell interactions: insights in melanoma progression and therapy

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Exosomes are extracellular vesicles mediating cell-to-cell communication.
• Melanoma-derived exosomes (MEXs) contribute to tumor progression by modulating the immune response.
• MEXs transfer oncogenic signals and immunosuppressive factors, creating a tumor-promoting microenvironment.

Purpose of the Study:

• To review the molecular composition of MEXs.
• To elucidate the mechanisms by which MEXs influence the immune system.
• To explore the potential of MEXs as therapeutic targets and biomarkers in melanoma.

Main Methods:

• Literature review of studies on exosome biology and melanoma immunology.
• Analysis of molecular cargo within MEXs, including proteins, lipids, and RNA.
• Examination of MEX-mediated interactions with immune cells like T cells, dendritic cells, myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs).

Main Results:

• MEXs suppress T cell and dendritic cell activation and proliferation.
• MEXs induce differentiation of MDSCs and Tregs, promoting immune suppression.
• MEXs facilitate immune evasion through apoptosis of CD8+ T cells and transfer of tumor antigens.
• MEXs shuttle immunosuppressive cytokines (IL-10, TGF-β) and express PD-L1, contributing to an immunosuppressive tumor microenvironment.

Conclusions:

• MEXs play a critical role in establishing an immunosuppressive microenvironment that favors melanoma growth.
• Targeting MEX-mediated mechanisms could enhance anti-melanoma immunity.
• MEXs hold potential as biomarkers for melanoma diagnosis and prognosis.
• Leveraging exosome accumulation in melanoma tissues could improve treatment delivery and reduce side effects.